UCB SA (EBR:UCB)
232.20
+4.20 (1.84%)
Nov 19, 2025, 3:24 PM CET
UCB SA Revenue
UCB SA had revenue of 3.49B EUR in the half year ending June 30, 2025, with 38.43% growth. This brings the company's revenue in the last twelve months to 6.85B, up 25.56% year-over-year. In the year 2024, UCB SA had annual revenue of 6.15B with 18.72% growth.
Revenue (ttm)
6.85B
Revenue Growth
+25.56%
P/S Ratio
6.33
Revenue / Employee
796.28K
Employees
9,378
Market Cap
43.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.15B | 970.00M | 18.72% |
| Dec 31, 2023 | 5.18B | -265.00M | -4.87% |
| Dec 31, 2022 | 5.45B | -330.00M | -5.71% |
| Dec 31, 2021 | 5.78B | 430.00M | 8.04% |
| Dec 31, 2020 | 5.35B | 434.00M | 8.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| argenx SE | 3.14B |
| Fagron NV | 918.75M |
| Ion Beam Applications | 585.76M |
| European Medical Solutions | 49.47M |
| Biocartis Group NV | 47.69M |
| Hyloris Pharmaceuticals | 8.46M |
| Nyxoah | 5.64M |
| Onward Medical | 2.72M |
UCB SA News
- 2 days ago - PGIM Jennison Health Sciences Fund Q3 2025 Contributors And Detractors - Seeking Alpha
- 11 days ago - Decoding United Community Banks Inc (UCB): A Strategic SWOT Insight - GuruFocus
- 14 days ago - Half Year 2025 Ucb SA Earnings Call Transcript - GuruFocus
- 15 days ago - U.S. FDA approves KYGEVVI® (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d) - PRNewsWire
- 21 days ago - Insider Sell: Richard Bradshaw Sells Shares of United Community Banks Inc (UCB) - GuruFocus
- 27 days ago - United Community Banks, Inc. (UCB) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - UCB Reports Strong Q3 Results with Significant Growth in Revenue and Loans - GuruFocus
- 4 weeks ago - United Community Banks Inc. Announces Rise In Q3 Bottom Line - Nasdaq